On Dec. 21, Aurora Cannabis (NYSE: ACB) announced that its chief corporate officer, Cam Battley, would be leaving the company to work for MedReleaf Australia. Aurora owns a 10% stake in MedReleaf and has 50% voting rights in the company.
Earlier in the month, Neil Belot also decided to leave the company, although Aurora made no formal announcement. It hired Belot in 2017 to be its chief global business development officer, helping with its international growth.
Anytime a company loses a key executive, let alone two (especially since it's struggling), it could be a cause for concern.